PCOS (Polycystic Ovary Syndrome) is one of the common hormonal disorders that is interconnected to weight changes in women.

This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity ...

According to the WHO, more than one billion people around the world are affected by obesity. By 2030, it says that figure ...

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

WHO outlines first-ever global recommendations for GLP-1 medicines in obesity care, stressing long-term use and behavioural support ...

The move comes even as the demand for the class of drugs known as GLP-1 agonists has increased across the world.

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic ...

Diabetes, obesity, and cardiovascular issues are interconnected, impacting millions in India. Meril and The Times of India's ...

That said, several key categories of biomarkers can provide meaningful insight into long-term health.

WHO has issued its first-ever guidance recommending GLP-1 drugs for long-term obesity management, marking a major shift from ...

Do diabetes and obesity raise pancreatic cancer risk? An oncologist shares 8 silent symptoms and prevention tips backed by recent research.